Showing results (1041-1050 of 7,630) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|March 22, 2006
False-negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosisEdward N Libby, Jessica K Booker, Margaret L Gulley, et al.American Journal of Hematology|March 22, 2006
Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literatureAnuradha Kunthur, Peter H Wiernik, Janice P DutcherAmerican Journal of Hematology|February 1, 1990
The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasiaJ Benbassat, D Gilon, S PenchasAmerican Journal of Hematology|March 1, 1990
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always betterJ B Bussel, J Fitzgerald-Pedersen, C FeldmanAmerican Journal of Hematology|May 1, 1990
"Idiopathic thrombocytopenic purpura-like syndrome" treated with interferon in a patient with lung cancerB L Rapoport, G Falkson, A S Alberts, et al.American Journal of Hematology|August 23, 2006
First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patientsSatoshi Gando, Atsushi Sawamura, Mineji Hayakawa, et al.American Journal of Hematology|August 23, 2006
A versatile denaturing HPLC approach for human beta-globin gene mutation screeningStavros N Bournazos, Aggeliki Tserga, George P Patrinos, et al.American Journal of Hematology|July 1, 1990
Variation in the level of fetal hemoglobin in (delta beta) (0)-thalassemia heterozygotes with different numbers of alpha-globin genesC Oner, A Gurgey, C Altay, et al.American Journal of Hematology|August 31, 2006
Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative studyGülsüm E Pamuk, Ozden Vural, Burhan Turgut, et al.American Journal of Hematology|August 29, 2006
Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patientJoanna K Law, Jaber Al Ali, P Richard Harrigan, et al.Pageof 763